Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis

Nephrology

Volumn 10, Issue 5, 2005, Pages 453-458

  Zumrutdal, Aysegul ^a   Sezer, Siren ^a   Demircan, Senol ^a   Seydaoglu, Gulsah ^b   Ozdemir, F Nurhan ^a   Haberal, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Beta 2 microglobulin; Cardiac troponin I; Carotid intima media thickness; Early onset atherosclerosis; Haematocrit corrected erythrocyte sedimentation rate; Inflammation

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; FIBRINOGEN; HOMOCYSTEINE; LIPID; LIPOPROTEIN A; TROPONIN I;

ADULT; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEMATOCRIT; HEMODIALYSIS; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGE OF ONSET; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL DIALYSIS; RISK FACTORS; TROPONIN I; TUNICA INTIMA; TUNICA MEDIA;

EID: 28444492299     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00475.x     Document Type: Article

References (28)

1. O'Leary DH, Polak JF. Intima-media thickness: A tool for atherosclerosis imaging and event prediction. Am. J. Cardiol. 2002; 90: 18-21.
2. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J. Am. Soc. Nephrol. 2001; 12: 2458-64.
3. Nakashima A, Yorioka N, Asakimori Y et al. Different risk factors for the maximum and the mean carotid intima-media thickness in hemodialysis patients. Intern. Med. 2003; 42: 1095-9.
4. Nishizawa Y, Shoji T, Maekawa K et al. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am. J. Kidney Dis. 2003; 41 (3 Suppl 1): 76-9.
5. Yamauchi T, Kuno T, Takada H et al. The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol. Dial. Transplant 2003; 18: 1842-7.
6. Sakurabayashi T, Fujimoto M, Takaesu Y et al. Association between plasma homocysteine concentration and carotid atherosclerosis in hemodialysis patients. Jpn Circ. J. 1999; 63: 692-6.
7. Papagianni A, Kalovoulus M, Kirmizis D et al. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol. Dial. Transplant 2003; 18: 113-19.
8. Magyar MT, Szikszai Z, Balla J et al. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke 2003; 34: 58-63.
9. Kato A, Takita T, Maruyama Y et al. Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int. 2003; 64: 1472-9.
10. Borawski J, Mysliwic M. The hematocrit corrected erythrocyte sedimentation rate can be useful in diagnosing inflammation in hemodialysis patients. Nephron 2001; 89: 381-3.
11. Lowbeer C, Stenvinkel P, Pecoits-Filho R et al. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J. Intern. Med. 2003; 253: 153-60.
12. Yeun JY, Kaysen GA. C-reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD. Curr. Opin. Nephrol. Hypertens. 2000; 9: 621-30.
13. Vraetz T, Ittel TH, Mackelenbergh MG, Heinrich PC, Sieberth HG, Graeve L. Regulation of β2-microglobulin expression in different human cell lines by proinflammatory cytokines. Nephrol. Dial. Transplant 1999; 14: 2137-43.
14. Santaro A, Mancini E. Cardiac effects of chronic inflammation in dialysis patients. Nephrol. Dial. Transplant 2002; 17 (Suppl. 8): 10-15.
15. Devereux RB, Koren MJ, Simone G, Okin PM, Kligfield P. Methods of detection of left ventricular hypertrophy: Application to hypertensive heart disease. Eur. Heart J. 1993; 14 (Suppl. D): 8-15.
16. Cheung AK, Sarnak MJ, Yan G et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000; 58: 353-62.
17. Hojs R, Hojs-Fabjan T, Balon BP. Atherosclerosis in patients with end-stage renal failure prior to initiation of hemodialysis. Ren. Fail. 2003; 25: 247-54.
18. Touboul PJ. Clinical impact of intima media measurement. Eur. J. Ultrasound 2002; 16: 105-13.
19. Brouillard M, Reade R, Boulanger E et al. Erythrocyte sedimentation rate, an underestimated tool in chronic renal failure. Nephrol. Dial. Transplant 1996; 11: 2244-7.
20. Xie J, Yi Q. Beta 2 microglobulin as a potential initiator of inflammatory responses. Trends Immunol. 2003; 24: 228-9.
21. Freda B, Tang W, Van Lente F et al. Cardiac troponins in renal insufficiency. Review and clinical implications. J. Am. Coll. Cardiol. 2002; 40: 2065-71.
22. Roppolo LP, Fitzgerald R, Dillow J et al. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran's Hospital: A pilot study. J. Am. Coll. Cardiol. 1999; 34: 448-54.
23. Iliou MC, Fumeron C, Benoit MO et al. Factors associated with increased serum levels of cardiac troponins T and I in chronic hemodialysis patients: Chronic hemodialysis and new cardiac markers evaluation (CHANCE) study. Nephrol. Dial. Transplant 2001; 16: 1452-8.
24. Koenig W. C-Reactive protein and cardiovascular risk: An update on what is going on in cardiology. Nephrol. Dial. Transplant 2003; 18: 1039-41.
25. Hashimoto H, Kitagawa K, Hougaku H et al. C-Reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001; 104: 63-7.
26. Massy ZA. Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end products) for atherogenesis in uraemic patients. Nephrol. Dial. Transplant 2000; 15 (Suppl. 5): 81-91.
27. Wanner C. Importance of hyperlipidemia and therapy in renal patients. Nephrol. Dial. Transplant 2000; 15 (Suppl. 5): 92-6.
28. Saygili A, Barutçu O, Cengiz N et al. Carotid intima media thickness and left ventricular changes in children with end stage renal disease. Transplant. Proc. 2002; 34: 2073-5.